CB2 cannabinoid receptors

K. Mackie, R. A. Ross

Research output: Contribution to journalComment/debate

14 Citations (Scopus)

Abstract

Over the years CB2 cannabinoid receptors have received much less attention than CB1 receptors, the latter mediating most of the psychoactive effects of cannabis. Primarily this was due to difficulties in assigning a physiological function to CB2 receptors. In recent years this situation has changed, and CB2 receptors have been implicated in processes as diverse as analgesia, hepatic fibrosis, bone growth, and atherosclerosis. This special issue of the British Journal of Pharmacology addresses these and other topics in CB2 receptor research by compiling a series of reviews and primary research papers stemming from a meeting 'CB2(2) cannabinoid receptors: New vistas' that was held in Banff, Canada, from May 31 to June 3, 2007.

Original languageEnglish
Pages (from-to)177-178
Number of pages2
JournalBritish Journal of Pharmacology
Volume153
Issue number2
DOIs
Publication statusPublished - Jan 2008

Keywords

  • cannabinoid
  • CB2
  • receptor
  • GPCR
  • anandamide
  • 2AG
  • knockout
  • AM1241

Cite this

CB2 cannabinoid receptors. / Mackie, K.; Ross, R. A.

In: British Journal of Pharmacology, Vol. 153, No. 2, 01.2008, p. 177-178.

Research output: Contribution to journalComment/debate

Mackie, K & Ross, RA 2008, 'CB2 cannabinoid receptors', British Journal of Pharmacology, vol. 153, no. 2, pp. 177-178. https://doi.org/10.1038/sj.bjp.0707617
Mackie, K. ; Ross, R. A. / CB2 cannabinoid receptors. In: British Journal of Pharmacology. 2008 ; Vol. 153, No. 2. pp. 177-178.
@article{5712876e1d0847f3aa980c31249f38f2,
title = "CB2 cannabinoid receptors",
abstract = "Over the years CB2 cannabinoid receptors have received much less attention than CB1 receptors, the latter mediating most of the psychoactive effects of cannabis. Primarily this was due to difficulties in assigning a physiological function to CB2 receptors. In recent years this situation has changed, and CB2 receptors have been implicated in processes as diverse as analgesia, hepatic fibrosis, bone growth, and atherosclerosis. This special issue of the British Journal of Pharmacology addresses these and other topics in CB2 receptor research by compiling a series of reviews and primary research papers stemming from a meeting 'CB2(2) cannabinoid receptors: New vistas' that was held in Banff, Canada, from May 31 to June 3, 2007.",
keywords = "cannabinoid, CB2, receptor, GPCR, anandamide, 2AG, knockout, AM1241",
author = "K. Mackie and Ross, {R. A.}",
year = "2008",
month = "1",
doi = "10.1038/sj.bjp.0707617",
language = "English",
volume = "153",
pages = "177--178",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - CB2 cannabinoid receptors

AU - Mackie, K.

AU - Ross, R. A.

PY - 2008/1

Y1 - 2008/1

N2 - Over the years CB2 cannabinoid receptors have received much less attention than CB1 receptors, the latter mediating most of the psychoactive effects of cannabis. Primarily this was due to difficulties in assigning a physiological function to CB2 receptors. In recent years this situation has changed, and CB2 receptors have been implicated in processes as diverse as analgesia, hepatic fibrosis, bone growth, and atherosclerosis. This special issue of the British Journal of Pharmacology addresses these and other topics in CB2 receptor research by compiling a series of reviews and primary research papers stemming from a meeting 'CB2(2) cannabinoid receptors: New vistas' that was held in Banff, Canada, from May 31 to June 3, 2007.

AB - Over the years CB2 cannabinoid receptors have received much less attention than CB1 receptors, the latter mediating most of the psychoactive effects of cannabis. Primarily this was due to difficulties in assigning a physiological function to CB2 receptors. In recent years this situation has changed, and CB2 receptors have been implicated in processes as diverse as analgesia, hepatic fibrosis, bone growth, and atherosclerosis. This special issue of the British Journal of Pharmacology addresses these and other topics in CB2 receptor research by compiling a series of reviews and primary research papers stemming from a meeting 'CB2(2) cannabinoid receptors: New vistas' that was held in Banff, Canada, from May 31 to June 3, 2007.

KW - cannabinoid

KW - CB2

KW - receptor

KW - GPCR

KW - anandamide

KW - 2AG

KW - knockout

KW - AM1241

U2 - 10.1038/sj.bjp.0707617

DO - 10.1038/sj.bjp.0707617

M3 - Comment/debate

VL - 153

SP - 177

EP - 178

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 2

ER -